Aurora Cannabis (ACB) Total Current Liabilities (2018 - 2025)
Aurora Cannabis (ACB) reported Total Current Liabilities of $77.3 million for Q1 2025, down 16.46% year-over-year from $92.5 million in Q1 2024, and down 16.46% quarter-over-quarter from $92.5 million in Q1 2024.
Aurora Cannabis (ACB) Total Current Liabilities (2018 - 2025) Analysis & Trends
Aurora Cannabis (ACB) has 8 years of Total Current Liabilities data on file, last reported at $77.3 million in Q1 2025.
- Total Current Liabilities for Q1 2025 came in at $77.3 million, down 16.46% year-over-year; the trailing twelve-month figure through Mar 2025 was $77.3 million (down 16.46% YoY), and the FY2025 annual result was $77.3 million, down 16.46% from the prior year.
- Total Current Liabilities eased to $77.3 million in Q1 2025 per ACB's latest filing, from $92.5 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $175.9 million in Q1 2023 and troughed at $77.3 million in Q1 2025.
- A 5-year average of $108.6 million and a median of $94.7 million in 2021 frame the typical range for Total Current Liabilities.
- The sharpest annual moves came in 2021 and 2022: Total Current Liabilities plunged 51.78% in 2021, then advanced 8.41% in 2022.
- A 5-year view of Total Current Liabilities shows it stood at $94.7 million in 2021, then gained by 8.41% to $102.6 million in 2022, then soared by 71.34% to $175.9 million in 2023, then tumbled by 47.41% to $92.5 million in 2024, then fell by 16.46% to $77.3 million in 2025.
- Business Quant data shows ACB's Total Current Liabilities at $77.3 million in Q1 2025, $92.5 million in Q1 2024, and $175.9 million in Q1 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 13.53 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 2.05 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 599.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 831.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 1.66 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 599.50 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 333.17 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 618.78 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 149.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 77.26 Mn |
| Mar 31, 2024 | 92.48 Mn |
| Mar 31, 2023 | 175.85 Mn |
| Jun 30, 2022 | 102.64 Mn |
| Jun 30, 2021 | 94.67 Mn |
| Jun 30, 2020 | 196.35 Mn |
| Jun 30, 2019 | 326.14 Mn |
| Jun 30, 2018 | 58.26 Mn |